These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 36003914

  • 1. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y, Ye T, Chen K, Wu G, Xia Y, Wang X, Zong G.
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [Abstract] [Full Text] [Related]

  • 2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C, Chen Z, Zhang J, Jin X, Yang M.
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [Abstract] [Full Text] [Related]

  • 3. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Yang L, Cong H, Lu Y, Chen X, Liu Y.
    Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L, Wang Y, Wang W, Wang Z.
    Sci Rep; 2024 Jun 02; 14(1):12634. PubMed ID: 38824158
    [Abstract] [Full Text] [Related]

  • 5. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
    Wu ZF, Su WT, Chen S, Xu BD, Zong GJ, Fang CM, Huang Z, Hu XJ, Wu GY, Ma XL.
    Ther Clin Risk Manag; 2023 Jun 02; 19():699-712. PubMed ID: 37641783
    [Abstract] [Full Text] [Related]

  • 6. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT, Lin ZR, Zhang L, Zhao ZW, Chen LL.
    BMC Cardiovasc Disord; 2022 Mar 18; 22(1):113. PubMed ID: 35300593
    [Abstract] [Full Text] [Related]

  • 7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H, Zhu Y, Shen G, Wang Z, Li W.
    Clin Interv Aging; 2023 Mar 18; 18():453-465. PubMed ID: 36987461
    [Abstract] [Full Text] [Related]

  • 8. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L, Zhang J, Huang Q, Cui R, Chen J.
    BMC Cardiovasc Disord; 2023 Apr 17; 23(1):198. PubMed ID: 37069503
    [Abstract] [Full Text] [Related]

  • 9. Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Xie E, Li Q, Ye Z, Guo Z, Li Y, Shen N, Yu C, Gao Y, Zheng J.
    Heliyon; 2023 Nov 17; 9(11):e21276. PubMed ID: 37920501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of risk factors for PCI no-reflow in coronary heart disease and construction of related prediction models.
    Zhang L, Lin J, Luo L, Liu B, Zeng X.
    Am J Transl Res; 2024 Nov 17; 16(8):3733-3741. PubMed ID: 39262730
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T, Balta S, Demır M, Yıldırım AO, Kaya MG, Ozturk C, Demırkol S, Unlu M, Kılıc S, Aydın İ, Iyısoy A.
    Cardiol J; 2016 Nov 17; 23(1):84-92. PubMed ID: 26503078
    [Abstract] [Full Text] [Related]

  • 14. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Wang L, Yang L, Li T, Geng S.
    J Inflamm Res; 2023 Nov 17; 16():3185-3196. PubMed ID: 37529768
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.
    Erkol A, Oduncu V, Turan B, Kılıçgedik A, Sırma D, Gözübüyük G, Karabay CY, Guler A, Dündar C, Tigen K, Pala S, Kırma C.
    J Thromb Thrombolysis; 2014 Oct 17; 38(3):339-47. PubMed ID: 24407374
    [Abstract] [Full Text] [Related]

  • 18. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z, Xu Y, Tang L, Wu M, Wu B, Zhu T, Wang J.
    Cardiovasc Diabetol; 2023 Apr 13; 22(1):87. PubMed ID: 37055777
    [Abstract] [Full Text] [Related]

  • 19. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
    Wang Y, Liu L, Li X, Dang Y, Li Y, Wang J, Qi X.
    J Interv Cardiol; 2022 Apr 13; 2022():8994106. PubMed ID: 35356419
    [Abstract] [Full Text] [Related]

  • 20. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP, Guo QC, Mu N, Liu CH.
    Medicine (Baltimore); 2024 Jun 14; 103(24):e38563. PubMed ID: 38875361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.